Aim High - Adjuvant interferon in melanoma (high-risk), a United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) a randomised study of observation versus adjuvant low dose extended duration interferon alpha-2a in high risk resected malignant melanoma

BW Hancock; Keith Wheatley; G Harrison; M Gore

Aim High - Adjuvant interferon in melanoma (high-risk), a United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) a randomised study of observation versus adjuvant low dose extended duration interferon alpha-2a in high risk resected malignant melanoma

BW Hancock
, Keith Wheatley
, G Harrison
, M Gore

Cancer Research UK Clinical Trials Unit

Research output: Contribution to conference (unpublished) › Abstract

Original language	English
Pages	349a
Publication status	Published - 1 Jan 2001
Event	Proc Am Soc Clin Concol - Duration: 1 Jan 2001 → …

Conference

Conference	Proc Am Soc Clin Concol
Period	1/01/01 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{79ef8de92edd438d98743219c544ba92,

title = "Aim High - Adjuvant interferon in melanoma (high-risk), a United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) a randomised study of observation versus adjuvant low dose extended duration interferon alpha-2a in high risk resected malignant melanoma",

author = "BW Hancock and Keith Wheatley and G Harrison and M Gore",

year = "2001",

month = jan,

day = "1",

language = "English",

pages = "349a",

note = "Proc Am Soc Clin Concol ; Conference date: 01-01-2001",

}

Aim High - Adjuvant interferon in melanoma (high-risk), a United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) a randomised study of observation versus adjuvant low dose extended duration interferon alpha-2a in high risk resected malignant melanoma. / Hancock, BW; Wheatley, Keith; Harrison, G et al.
2001. 349a Abstract from Proc Am Soc Clin Concol.

Research output: Contribution to conference (unpublished) › Abstract

TY - CONF

T1 - Aim High - Adjuvant interferon in melanoma (high-risk), a United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) a randomised study of observation versus adjuvant low dose extended duration interferon alpha-2a in high risk resected malignant melanoma

AU - Hancock, BW

AU - Wheatley, Keith

AU - Harrison, G

AU - Gore, M

PY - 2001/1/1

Y1 - 2001/1/1

M3 - Abstract

SP - 349a

T2 - Proc Am Soc Clin Concol

Y2 - 1 January 2001

ER -